Home » Topics » BioWorld Science

BioWorld Science
RSS

Caladrius Biosciences initiates phase II study of CLBS-14

May 17, 2018

FogPharma announces closing of series B financing

May 17, 2018

Hospira obtains FDA approval for epoetin alfa biosimilar Retacrit

May 17, 2018

SNP in ITGA4 gene tied to higher risk of Alzheimer's disease

May 17, 2018

Preliminary results reported from phase Ia/b study of LY-3300054 for solid tumors

May 17, 2018

FDA grants orphan drug designation to Sarconeos for Duchenne muscular dystrophy

May 17, 2018

Phase III study of galcanezumab in episodic cluster headache meets primary endpoint

May 17, 2018

NIAID files IND application for phase IIa study of next-generation pertussis vaccine BPZE-1

May 17, 2018

Sumitomo Dainippon updates pipeline activities of fourth quarter of fiscal 2017

May 17, 2018

Cipher acquires Correvio's Canadian business portfolio

May 17, 2018

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...